GSA Capital Partners’s Editas Medicine EDIT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.07M	Sell	434,413 -134,396	-24%	-$284K	0.07%	457
2025 Q4	$1.17M	Buy	+568,809	New	+$1.64M	0.1%	278
2025 Q3	–	Sell	-82,343	Closed	-$181K	–	1762
2025 Q2	$181K	Buy	+82,343	New	+$135K	0.01%	1533
2024 Q4	–	Sell	-182,725	Closed	-$623K	–	1705
2024 Q3	$623K	Buy	182,725 +86,020	+89%	+$374K	0.05%	774
2024 Q2	$452K	Buy	96,705 +49,303	+104%	+$278K	0.03%	1030
2024 Q1	$352K	Buy	+47,402	New	+$394K	0.03%	1112
2023 Q4	–	Sell	-20,141	Closed	-$157K	–	1591
2023 Q3	$157K	Buy	+20,141	New	+$173K	0.01%	1329
2023 Q2	–	Sell	-20,549	Closed	-$149K	–	1607
2023 Q1	$149K	Buy	20,549 +1,803	+10%	+$16K	0.01%	1306
2022 Q4	$166K	Sell	18,746 -1,760	-9%	-$19.3K	0.02%	1229
2022 Q3	$251K	Sell	20,506 -48,494	-70%	-$756K	0.03%	1049
2022 Q2	$816K	Buy	69,000 +56,876	+469%	+$762K	0.12%	221
2022 Q1	$231K	Buy	12,124 +923	+8%	+$17.2K	0.03%	1081
2021 Q4	$297K	Buy	11,201 +4,337	+63%	+$149K	0.04%	938
2021 Q3	$282K	Buy	+6,864	New	+$376K	0.03%	1061
2019 Q3	–	Sell	-15,817	Closed	-$391K	–	1471
2019 Q2	$391K	Sell	15,817 -16,283	-51%	-$389K	0.04%	821
2019 Q1	$785K	Buy	+32,100	New	+$727K	0.08%	426
2018 Q2	–	Sell	-26,285	Closed	-$871K	–	1741
2018 Q1	$871K	Buy	+26,285	New	+$937K	0.05%	751
2017 Q4	–	Sell	-27,800	Closed	-$667K	–	1611
2017 Q3	$667K	Buy	+27,800	New	+$529K	0.05%	774